Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

被引：0
|
作者：
Qi Chen
Zi Wang
Jicheng Lv
Lijun Liu
Hang Li
Weiwei Sun
Yanhong Huo
Yingbo Guo
Cun Shen
Shichao Li
Zhenjie Chen
Jingwei Zhou
机构：
[1] The First Affiliated Hospital of Beijing University of Chinese Medicine,Department of Nephrology, Dongzhimen Hospital
[2] Peking University First Hospital,Renal Division
[3] Institute of Nephrology,Department of Nephrology
[4] Peking University and Key Laboratory of Renal Disease,Department of Nephrology
[5] Ministry of Health of China,Department of Nephrology, Dongfang Hospital
[6] Peking Union Medical College Hospital,Department of Nephrology
[7] the 7th Medical Center of PLA General Hospital,undefined
[8] The Second Affiliated Hospital of Beijing University of Chinese Medicine,undefined
[9] Beijing Chinese Medicine Hospital Affiliated to Capital Medical University,undefined
来源：
Trials | / 23卷
关键词：
IgA nephropathy; Artesunate; Proteinuria;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Chen, Qi
    Wang, Zi
    Lv, Jicheng
    Liu, Lijun
    Li, Hang
    Sun, Weiwei
    Huo, Yanhong
    Guo, Yingbo
    Shen, Cun
    Li, Shichao
    Chen, Zhenjie
    Zhou, Jingwei
    [J]. TRIALS, 2022, 23 (01)
  • [2] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Liang Dai
    Linda L. D. Zhong
    Yan Cao
    Wei Chen
    Ying Cheng
    Xiu-Fang Lin
    Zhao-Xiang Bian
    Ai-Ping Lu
    [J]. Trials, 17
  • [3] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Dai, Liang
    Zhong, Linda L. D.
    Cao, Yan
    Chen, Wei
    Cheng, Ying
    Lin, Xiu-Fang
    Bian, Zhao-Xiang
    Lu, Ai-Ping
    [J]. TRIALS, 2016, 17
  • [4] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    [J]. Trials, 22
  • [5] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    [J]. TRIALS, 2021, 22 (01)
  • [6] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy
    Rizk, Dana
    Perkovic, Vlado
    Lafayette, Richard A.
    Trimarchi, Hernan
    Barratt, Jonathan
    Carroll, Kevin
    Tesar, Vladimir
    Zhang, Hong
    Suzuki, Yusuke
    Liew, Adrian
    Wong, Muh Geot
    Leslie, Bruce R.
    Mathur, Mohit
    Hafkin, Jeffrey
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 799 - 799
  • [7] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [8] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    [J]. ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [9] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [10] Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
    Yuanlong Sun
    Na Hu
    Gaofeng Chen
    Yanjie Wang
    Yiyang Hu
    Maojun Ge
    Yu Zhao
    [J]. Trials, 23
12345